Publications

Health-Related Quality-Of-Life Results from the Phase 3 Optimismm Study: Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

AuthID
P-00S-XYY

Author(s)

Weisel, K

Dimopoulos, M

Moreau, P

Yagci, M

Larocca, A

Kanate, AS

Vural, F

Cascavilla, N

Basu, S

Johnson, P

[+6]·

Krauth, MT

Lucio, P

Ben Yehuda, D

Mendeleeva, L

Guo, SE

Yu, X

Grote, L

Biyukov, T

Dhanasiri, S

Richardson, P

View all authors

Document Type

Article in Press

Year published

2020

Published

in LEUKEMIA & LYMPHOMA, ISSN: 1042-8194

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1080/10428194.2020.1747066

Wos: WOS:000558375200001

Source Identifiers

ISSN: 1042-8194

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Name	Name Order	Name	Name Order	Name
1	Weisel, K;	2	Dimopoulos, M;	3	Moreau, P;
4	Yagci, M;	5	Larocca, A;	6	Kanate, AS;
7	Vural, F;	8	Cascavilla, N;	9	Basu, S;
10	Johnson, P;	11	Byeff, P;	12	Hus, M;
13	Rodriguez Otero, P;	14	Muelduer, E;	15	Anttila, P;
16	Hayden, PJ;	17	Krauth, MT;	18	Lucio, P;
19	Ben Yehuda, D;	20	Mendeleeva, L;	21	Guo, SE;
22	Yu, X;	23	Grote, L;	24	Biyukov, T;
25	Dhanasiri, S;	26	Richardson, P;

Health-Related Quality-Of-Life Results from the Phase 3 Optimismm Study: Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Useful Links

Get Help

Federated Authentication (Click on the image)

Health-Related Quality-Of-Life Results from the Phase 3 Optimismm Study: Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Useful Links

Get Help